Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
181,793
-
Share change
-
-2,802
-
Total reported value
-
$150,424
-
Price per share
-
$0.83
-
Number of holders
-
11
-
Value change
-
-$16,235
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Predictive Oncology Inc. - COM (POAI) as of Q2 2025
As of 30 Jun 2025,
Predictive Oncology Inc. - COM (POAI) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
181,793 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, STATE STREET CORP, CARNEGIE MELLON UNIVERSITY, RAYMOND JAMES FINANCIAL INC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.